Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
ENDVEndonovo Therapeutics, Inc.
| Figure | ENDVEndonovo Therapeutics, Inc.FY2022 · Dec |
|---|---|
| Revenue | $135.36K |
| Revenue, yoy | +85.2% |
| Net income | $18.47M |
| Net income, yoy | −495.0% |
| Net margin | -13,649.2% |
| Free cash flow | $2.54M |
| FCF margin | — |
| EPS, diluted | $0.05 |
Add another company.
Annual · FY2018–FY2022 · USD
From SEC EDGARSame fiscal periods, as filed